Aeovian Pharmaceuticals, Inc. — Form D

Aeovian Pharmaceuticals, Inc. of Berkeley, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-13. The offering totals $50.4M, of which $50.4M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Lars C EkmDirectorBerkeley, CA
Richard C GasterDirectorBerkeley, CA
William C GreeneDirectorBerkeley, CA
Nils C ReggeDirectorBerkeley, CA
John F KincaidExecutive OfficerBerkeley, CA
Matthew J PlunkettExecutive OfficerBerkeley, CA
Davis C RymanExecutive OfficerBerkeley, CA
John J KincaidExecutive OfficerBerkeley, CA
Youssef J BennaniDirectorBerkeley, CA
Themasap J KhanDirectorBerkeley, CA
Nils J ReggeDirectorBerkeley, CA
Davis J RymanExecutive OfficerBerkeley, CA
William J GreeneDirectorBerkeley, CA
Micah J ZajicExecutive OfficerBerkeley, CA
Lars J EkmanDirectorBerkeley, CA
Justin J GoverDirectorBerkeley, CA
Allison J HulmeDirectorBerkeley, CA
Allison J HulmeExecutive OfficerBerkeley, CA
Richard J GasterDirectorBerkeley, CA
David LoweDirectorWalnut Creek, CA
James PeyerDirectorNew York, NY
Richard GasterDirectorWaltham, MA
Jens EcksteinDirectorCambridge, MA
Ben ZadikExecutive OfficerSan Francisco, CA
Michael PowellDirectorCambridge, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2025-12-22D$55.0M$55.0M
2019-10-09D$48.8M$18.8M
2017-06-28D$3.8M$786K

More